Our newly identified binding partner of DNMT3B, PHF14, has been previously shown to promote tumorigenesis and cancer progression by regulating cell mitosis, epithelial-mesenchymal transition, and Wnt and Akt signaling in multiple cancer types64–68. Here, DNMT3B is linked to cancer.